Alzheimer’s Disease Experts
- Dr Paula McClean
Learn more about our current research projects.
By understanding the interplay of disease with the sequence, expression level, and activation states of genes and other molecules within our bodies, we are creating a new generation of treatments and robust diagnostics to inform clinical decision making across a range of chronic and degenerative diseases.
To achieve this, the centre combines deep expertise in data analytics, disease pathogenesis, biomarker discovery, and translational medicine.
A list of the centre’s combined published research outputs can be found here via Pure.
Individual staff profiles and full details of all outputs can be found via the People tab.
We have collated an integrated disease sample biobank, enriched with clinical data and robust laboratory measures of genomic, proteomic and metabolomic determinants. This resource aims to facilitate the discovery and validation of biomarkers associated with disease predisposition and response to therapy, and ultimately more effective drugs.
We have collated an integrated disease sample biobank, enriched with clinical data and robust laboratory measures of genomic, proteomic and metabolomic determinants. This resource aims to facilitate the discovery and validation of biomarkers associated with disease predisposition and response to therapy, and ultimately more effective drugs.
Core resources include:
Ulster University's BMSRI and the Personalised Medicine Centre have extensive capabilities in human tissue storage, processing and analyses, utilising a barcoded computerised system compliant with the Human Tissue Act (HTA).
The Unit is managed by a Quality Assurance Officer as a core facility with a dedicated support team with access to: